Fate and distribution of an antitumor protein-bound polysaccharide PSK (Krestin ®)

The fate of 14C-labelled PSK in the body was investigated. Although only substances with low mol. wt were observed in blood shortly after the administration, with time, substances with high mol. wt appeared, suggesting absorption of PSK in its original form from the digestive tract. 14C-labelled PSK...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of immunopharmacology 1988, Vol.10 (4), p.415-423
Hauptverfasser: IKUZAWA, M, MATSUNAGA, K, YOSHIKUMI, C, NISHIYAMA, S, NAKAJIMA, S, KOBAYASHI, Y, ANDOH, T, KOBAYASHI, A, OHHARA, M, OHMURA, Y, WADA, T
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 423
container_issue 4
container_start_page 415
container_title International journal of immunopharmacology
container_volume 10
creator IKUZAWA, M
MATSUNAGA, K
YOSHIKUMI, C
NISHIYAMA, S
NAKAJIMA, S
KOBAYASHI, Y
ANDOH, T
KOBAYASHI, A
OHHARA, M
OHMURA, Y
WADA, T
description The fate of 14C-labelled PSK in the body was investigated. Although only substances with low mol. wt were observed in blood shortly after the administration, with time, substances with high mol. wt appeared, suggesting absorption of PSK in its original form from the digestive tract. 14C-labelled PSK was distributed in bone marrow, salivary gland, brain, liver, spleen, pancreas and tumor. Approximately 70% of 14C-labelled PSK was excreted by expiratory air after 24 h and approximately 15–20% in urine after 72 h. Only a small amount of 14C-labelled PSK was transferred into lymph and bile. The present study on the in vivo behavior of PSK provides an important basis for further analysis of its pharmacological actions.
doi_str_mv 10.1016/0192-0561(88)90128-2
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78454345</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0192056188901282</els_id><sourcerecordid>78454345</sourcerecordid><originalsourceid>FETCH-LOGICAL-c452t-36855ecdb69347e4934ac7c4a2bfebf2d0757811336022a345fe1d4b0ee215b3</originalsourceid><addsrcrecordid>eNp9kMFKAzEQQIMotVb_QGEPInpYTbLJbvYiiFgVBYX2HrLJLEa2m5pkBX_Kj_DLTG3pUQjJkHkzmTyEjgm-JJiUV5jUNMe8JOdCXNSYUJHTHTQmoqrzgtV8F423yD46COEdY8xJSUdoVJAqxXyMZlMVIVO9yYwN0dtmiNb1mWvTXVrRxmHhfLb0LoLt88YNCV267isord-Utway19lTdv7kIUTbZz_fF4dor1VdgKPNOUHz6d389iF_frl_vL15zjXjNOZFKTgHbZqyLlgFLO1KV5op2rTQtNTgileCkKIoMaWqYLwFYliDASjhTTFBZ-u2abiPIb0uFzZo6DrVgxuCrATjLFUlkK1B7V0IHlq59Hah_JckWK5UypUnufIkhZB_KiVNZSeb_kOzALMt2rhL-dNNXgWtutarXtuwxRJE6_S1CbpeY5BUfFrwMmgLvQZjPegojbP_z_ELfiGPUQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78454345</pqid></control><display><type>article</type><title>Fate and distribution of an antitumor protein-bound polysaccharide PSK (Krestin ®)</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>IKUZAWA, M ; MATSUNAGA, K ; YOSHIKUMI, C ; NISHIYAMA, S ; NAKAJIMA, S ; KOBAYASHI, Y ; ANDOH, T ; KOBAYASHI, A ; OHHARA, M ; OHMURA, Y ; WADA, T</creator><creatorcontrib>IKUZAWA, M ; MATSUNAGA, K ; YOSHIKUMI, C ; NISHIYAMA, S ; NAKAJIMA, S ; KOBAYASHI, Y ; ANDOH, T ; KOBAYASHI, A ; OHHARA, M ; OHMURA, Y ; WADA, T</creatorcontrib><description>The fate of 14C-labelled PSK in the body was investigated. Although only substances with low mol. wt were observed in blood shortly after the administration, with time, substances with high mol. wt appeared, suggesting absorption of PSK in its original form from the digestive tract. 14C-labelled PSK was distributed in bone marrow, salivary gland, brain, liver, spleen, pancreas and tumor. Approximately 70% of 14C-labelled PSK was excreted by expiratory air after 24 h and approximately 15–20% in urine after 72 h. Only a small amount of 14C-labelled PSK was transferred into lymph and bile. The present study on the in vivo behavior of PSK provides an important basis for further analysis of its pharmacological actions.</description><identifier>ISSN: 0192-0561</identifier><identifier>EISSN: 1879-3495</identifier><identifier>DOI: 10.1016/0192-0561(88)90128-2</identifier><identifier>PMID: 3170055</identifier><identifier>CODEN: IJIMDS</identifier><language>eng</language><publisher>Oxford: Elsevier Science</publisher><subject>Absorption ; Animals ; Antibiotics, Antineoplastic - pharmacokinetics ; Antibiotics, Antineoplastic - pharmacology ; Biological and medical sciences ; Immunomodulators ; Lymphatic System - metabolism ; Medical sciences ; Mice ; Mice, Inbred ICR ; Molecular Weight ; Pharmacology. Drug treatments ; Proteoglycans - pharmacokinetics ; Proteoglycans - pharmacology ; Rabbits ; Rats ; Tissue Distribution</subject><ispartof>International journal of immunopharmacology, 1988, Vol.10 (4), p.415-423</ispartof><rights>1988</rights><rights>1989 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c452t-36855ecdb69347e4934ac7c4a2bfebf2d0757811336022a345fe1d4b0ee215b3</citedby><cites>FETCH-LOGICAL-c452t-36855ecdb69347e4934ac7c4a2bfebf2d0757811336022a345fe1d4b0ee215b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4010,27900,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=7002969$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3170055$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>IKUZAWA, M</creatorcontrib><creatorcontrib>MATSUNAGA, K</creatorcontrib><creatorcontrib>YOSHIKUMI, C</creatorcontrib><creatorcontrib>NISHIYAMA, S</creatorcontrib><creatorcontrib>NAKAJIMA, S</creatorcontrib><creatorcontrib>KOBAYASHI, Y</creatorcontrib><creatorcontrib>ANDOH, T</creatorcontrib><creatorcontrib>KOBAYASHI, A</creatorcontrib><creatorcontrib>OHHARA, M</creatorcontrib><creatorcontrib>OHMURA, Y</creatorcontrib><creatorcontrib>WADA, T</creatorcontrib><title>Fate and distribution of an antitumor protein-bound polysaccharide PSK (Krestin ®)</title><title>International journal of immunopharmacology</title><addtitle>Int J Immunopharmacol</addtitle><description>The fate of 14C-labelled PSK in the body was investigated. Although only substances with low mol. wt were observed in blood shortly after the administration, with time, substances with high mol. wt appeared, suggesting absorption of PSK in its original form from the digestive tract. 14C-labelled PSK was distributed in bone marrow, salivary gland, brain, liver, spleen, pancreas and tumor. Approximately 70% of 14C-labelled PSK was excreted by expiratory air after 24 h and approximately 15–20% in urine after 72 h. Only a small amount of 14C-labelled PSK was transferred into lymph and bile. The present study on the in vivo behavior of PSK provides an important basis for further analysis of its pharmacological actions.</description><subject>Absorption</subject><subject>Animals</subject><subject>Antibiotics, Antineoplastic - pharmacokinetics</subject><subject>Antibiotics, Antineoplastic - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Immunomodulators</subject><subject>Lymphatic System - metabolism</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Inbred ICR</subject><subject>Molecular Weight</subject><subject>Pharmacology. Drug treatments</subject><subject>Proteoglycans - pharmacokinetics</subject><subject>Proteoglycans - pharmacology</subject><subject>Rabbits</subject><subject>Rats</subject><subject>Tissue Distribution</subject><issn>0192-0561</issn><issn>1879-3495</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1988</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMFKAzEQQIMotVb_QGEPInpYTbLJbvYiiFgVBYX2HrLJLEa2m5pkBX_Kj_DLTG3pUQjJkHkzmTyEjgm-JJiUV5jUNMe8JOdCXNSYUJHTHTQmoqrzgtV8F423yD46COEdY8xJSUdoVJAqxXyMZlMVIVO9yYwN0dtmiNb1mWvTXVrRxmHhfLb0LoLt88YNCV267isord-Utway19lTdv7kIUTbZz_fF4dor1VdgKPNOUHz6d389iF_frl_vL15zjXjNOZFKTgHbZqyLlgFLO1KV5op2rTQtNTgileCkKIoMaWqYLwFYliDASjhTTFBZ-u2abiPIb0uFzZo6DrVgxuCrATjLFUlkK1B7V0IHlq59Hah_JckWK5UypUnufIkhZB_KiVNZSeb_kOzALMt2rhL-dNNXgWtutarXtuwxRJE6_S1CbpeY5BUfFrwMmgLvQZjPegojbP_z_ELfiGPUQ</recordid><startdate>1988</startdate><enddate>1988</enddate><creator>IKUZAWA, M</creator><creator>MATSUNAGA, K</creator><creator>YOSHIKUMI, C</creator><creator>NISHIYAMA, S</creator><creator>NAKAJIMA, S</creator><creator>KOBAYASHI, Y</creator><creator>ANDOH, T</creator><creator>KOBAYASHI, A</creator><creator>OHHARA, M</creator><creator>OHMURA, Y</creator><creator>WADA, T</creator><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1988</creationdate><title>Fate and distribution of an antitumor protein-bound polysaccharide PSK (Krestin ®)</title><author>IKUZAWA, M ; MATSUNAGA, K ; YOSHIKUMI, C ; NISHIYAMA, S ; NAKAJIMA, S ; KOBAYASHI, Y ; ANDOH, T ; KOBAYASHI, A ; OHHARA, M ; OHMURA, Y ; WADA, T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c452t-36855ecdb69347e4934ac7c4a2bfebf2d0757811336022a345fe1d4b0ee215b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1988</creationdate><topic>Absorption</topic><topic>Animals</topic><topic>Antibiotics, Antineoplastic - pharmacokinetics</topic><topic>Antibiotics, Antineoplastic - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Immunomodulators</topic><topic>Lymphatic System - metabolism</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Inbred ICR</topic><topic>Molecular Weight</topic><topic>Pharmacology. Drug treatments</topic><topic>Proteoglycans - pharmacokinetics</topic><topic>Proteoglycans - pharmacology</topic><topic>Rabbits</topic><topic>Rats</topic><topic>Tissue Distribution</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>IKUZAWA, M</creatorcontrib><creatorcontrib>MATSUNAGA, K</creatorcontrib><creatorcontrib>YOSHIKUMI, C</creatorcontrib><creatorcontrib>NISHIYAMA, S</creatorcontrib><creatorcontrib>NAKAJIMA, S</creatorcontrib><creatorcontrib>KOBAYASHI, Y</creatorcontrib><creatorcontrib>ANDOH, T</creatorcontrib><creatorcontrib>KOBAYASHI, A</creatorcontrib><creatorcontrib>OHHARA, M</creatorcontrib><creatorcontrib>OHMURA, Y</creatorcontrib><creatorcontrib>WADA, T</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of immunopharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>IKUZAWA, M</au><au>MATSUNAGA, K</au><au>YOSHIKUMI, C</au><au>NISHIYAMA, S</au><au>NAKAJIMA, S</au><au>KOBAYASHI, Y</au><au>ANDOH, T</au><au>KOBAYASHI, A</au><au>OHHARA, M</au><au>OHMURA, Y</au><au>WADA, T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fate and distribution of an antitumor protein-bound polysaccharide PSK (Krestin ®)</atitle><jtitle>International journal of immunopharmacology</jtitle><addtitle>Int J Immunopharmacol</addtitle><date>1988</date><risdate>1988</risdate><volume>10</volume><issue>4</issue><spage>415</spage><epage>423</epage><pages>415-423</pages><issn>0192-0561</issn><eissn>1879-3495</eissn><coden>IJIMDS</coden><abstract>The fate of 14C-labelled PSK in the body was investigated. Although only substances with low mol. wt were observed in blood shortly after the administration, with time, substances with high mol. wt appeared, suggesting absorption of PSK in its original form from the digestive tract. 14C-labelled PSK was distributed in bone marrow, salivary gland, brain, liver, spleen, pancreas and tumor. Approximately 70% of 14C-labelled PSK was excreted by expiratory air after 24 h and approximately 15–20% in urine after 72 h. Only a small amount of 14C-labelled PSK was transferred into lymph and bile. The present study on the in vivo behavior of PSK provides an important basis for further analysis of its pharmacological actions.</abstract><cop>Oxford</cop><pub>Elsevier Science</pub><pmid>3170055</pmid><doi>10.1016/0192-0561(88)90128-2</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0192-0561
ispartof International journal of immunopharmacology, 1988, Vol.10 (4), p.415-423
issn 0192-0561
1879-3495
language eng
recordid cdi_proquest_miscellaneous_78454345
source MEDLINE; Alma/SFX Local Collection
subjects Absorption
Animals
Antibiotics, Antineoplastic - pharmacokinetics
Antibiotics, Antineoplastic - pharmacology
Biological and medical sciences
Immunomodulators
Lymphatic System - metabolism
Medical sciences
Mice
Mice, Inbred ICR
Molecular Weight
Pharmacology. Drug treatments
Proteoglycans - pharmacokinetics
Proteoglycans - pharmacology
Rabbits
Rats
Tissue Distribution
title Fate and distribution of an antitumor protein-bound polysaccharide PSK (Krestin ®)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T19%3A51%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fate%20and%20distribution%20of%20an%20antitumor%20protein-bound%20polysaccharide%20PSK%20(Krestin%20%C2%AE)&rft.jtitle=International%20journal%20of%20immunopharmacology&rft.au=IKUZAWA,%20M&rft.date=1988&rft.volume=10&rft.issue=4&rft.spage=415&rft.epage=423&rft.pages=415-423&rft.issn=0192-0561&rft.eissn=1879-3495&rft.coden=IJIMDS&rft_id=info:doi/10.1016/0192-0561(88)90128-2&rft_dat=%3Cproquest_cross%3E78454345%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78454345&rft_id=info:pmid/3170055&rft_els_id=0192056188901282&rfr_iscdi=true